Almost without fail you see a secondary offering on a huge move in a small biotech. PURE's financial position is probably much better than most but it wouldn't surprise me to see a secondary in the next few days. Would be a good time to move back in on the pullback.
No doubt about it, another issuance is at hand. PIPE city like the last time it ran up. Krall needs to sell stock constantly. Cash flow positive was years ago yet investors keep rewarding this carnival barker.